Validation of genomic markers that predict distant recurrence risk via FISH assays in women with early stage breast carcinoma

10506 Background: Biomarkers offer the potential to better predict recurrence risk in early stage invasive breast cancer, especially if adaptable to common assays such as fluorescent in situ hybrid...